IID 14: Vaginal Infections Flashcards

1
Q

Vaginal Discharge

A
  • normal: thick/thin, white/clear
  • BV: thin, copious amounts, grey/milky
  • VVC: curd-like, clumpy, white
  • trichomoniasis: frothy, yellow-green or off-white
  • PMAV: possible, usually vaginal dryness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dysuria/Dyspareunia

A
  • normal: none
  • BV: possible
  • VVC: possible
  • trichomoniasis: possible
  • PMAV: possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pruritus

A
  • normal: none
  • BV: usually none
  • VVC: yes
  • trichomoniasis: yes
  • PMAV: possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Abnormal Odour

A
  • normal: no
  • BV: yes, fishy
  • VVC: no
  • trichomoniasis: yes, very fishy
  • PMAV: no
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Erythema Swelling

A
  • normal: none
  • BV: none to mild
  • VVC: yes
  • trichomoniasis: yes
  • PMAV: no
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pH

A
  • normal: 3.8-4.5
  • BV: 5-6
  • VVC: 4-5
  • trichomoniasis: ≥ 6
  • PMAV: ~7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sexual Transmission

A
  • BV: no
  • VVC: no
  • trichomoniasis: yes
  • PMAV: no
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Organism

A
  • BV: Gardnerella vaginalis
  • VVC: C. albicans (> 90%), C. glabrata (5-10%), C. tropicalis (5%), C. krusei (1%)
  • trichomoniasis: Trichomonas vaginalis
  • PMAV: none
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Microscopy

A
  • normal: Lactobacilli, negative whiff test
  • BV: clue cells, positive whiff test
  • VVC: Candida species, negative whiff test
  • trichomoniasis: motile trichomonads, + or – whiff
  • PMAV: typically ↓ in Lactobacillus spp.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Serious Complication (Untreated)

A
  • BV: 2x increase in miscarriage, pelvic inflamm disease (PID)
  • VVC: none
  • trichomoniasis: pre-term birth, low birth weight
  • PMAV: none
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Refer to MD

A
  • BV: yes
  • VVC: 1st time, other complications
  • trichomoniasis: yes
  • PMAV: yes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathogenesis of VVC?

A
  • adhesion of single yeast cells triggered by change in environment (ie. pH or hormones)
  • cells proliferate then form elongated projections that continue to grow into filamentous hyphal form
  • hyphae filaments stick to mucous layer and form biofilm, non-adherent yeast cells are released from biofilm into surroundings where they can colonize other surfaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Usual Treatment

A
  • BV: Rx antibiotics (metronidazole, clindamycin)
  • VVC: OTC oral, topical antifungals (fluconazole, miconazole, clotrimazole)
  • trichomoniasis: Rx antibiotics (metronidazole)
  • PMAV: Rx topical estrogen, or OTC vaginal moisturizers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Does the partner of someone who has VCC need to be treated?

A

not necessary to treat partner unless symptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the predisposing factors for VVC?

A
  • often absent
  • sexually active
  • poorly controlled diabetes
  • immunocompromised (corticosteroids, chemotherapy, HIV)
  • current or recent antibiotic use, some diabetic drugs
  • hormonal (pregnancy, oral contraceptives, hormone replacement)
  • smoking may decrease Lactobacilli species
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the characteristics of uncomplicated VVC?

A

patient must have all:

  • symptoms: mild or moderate
  • frequency: sporadic or infrequent
  • organism: C. albicans
  • host factors: normal immune function, non-pregnant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the characteristics of complicated VVC?

A

patient must have 1 or more:

  • symptoms: severe
  • frequency: recurrent
  • organism: C. non-albicans
  • host factors: abnormal immune function, pregnant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the patient-specific factors that indicate a need for a referral?

A
  • age: pre-pubertal or post-menopausal patient
  • STI: considered at risk
  • pregnant: first yeast infection while pregnant OR having multiple yeast infections
  • concurrent predisposing medical conditions (ie. diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the symptoms that indicate a need for a referral?

A
  • no prior diagnosis of VVC
  • symptoms not consistent with VVC
  • less than 2 months since previous occurrence
  • ≥ 2 VVC episodes in past 6 months
  • symptoms have not improved after 3 days of treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the antifungals used to treat VVC?

A
  • imidazoles (azoles)
  • triazoles
  • polyene antifungal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the antiseptics used to treat VVC?

A

boric acid (pv) – compounded 600 mg vaginal capsules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Imidazoles (Azoles) for VVC

A
  • sched 3: miconazole (pv)
  • sched 3: clotrimazole (pv)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Triazoles for VVC

A
  • sched 3: fluconazole (po) – sold as single 150 mg tablet for VVC
  • sched 1: terconazole (pv) – Taro-Terconazole© vaginal cream 0.4%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Polyene Antifungal for VVC

A
  • sched 1: nystatin (pv) – Nyaderm© or Teva-Nystatin© vaginal cream 25 000 units/g
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the side effects of imidazoles?

A
  • stinging, burning (itching if sensitive), allergy, headache, abdominal cramps
  • clotrimazole reported to cause less stinging than miconazole
  • if stinging occurs with higher dose product, try switching to lower dose for longer duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the drug interactions with imidazoles?

A

topical miconazole may increase serum concentration of warfarin

25
Q

What are the side effects for a single 150 mg dose of fluconazole?

A

headache (13%), nausea (7%), abdominal pain (6%), diarrhea (3%), dyspepsia (1%), dizziness (1%), taste perversion (1%), rare cases of anaphylaxis

26
Q

What are the interactions with fluconazole?

A
  • strong inhibitor of CYP2C9, moderate inhibitor of CYP3A4 and 2C19 – but interactions with single dose likely minimal
  • monitor warfarin, phenytoin, blood sugars with some oral diabetes agents
  • absorption not affected by food, gastric pH
27
Q

What are the side effects of boric acid?

A
  • ~10% vaginal burning and irritation
  • erythema
  • watery discharge
28
Q

What are the interactions with boric acid?

A
  • pregnancy – teratogenic, lack of safety data
  • not recommended in lactating women
29
Q

What is the primary therapy for uncomplicated VVC?

A
  • topical antifungal agents, with no one superior agent (strong rec – high-quality evidence)
  • alternative: single 150-mg oral dose of fluconazole (strong rec – high-quality evidence)
  • duration of therapy: start with shorter course (1-3 days) – more convenient and still > 90% effective
30
Q

What is the speed of symptom resolution for uncomplicated VVC?

A
  • conflicting results for time to symptom relief (oral vs. vaginal)
  • should be some relief by 2-3 days, full resolution within 7 day (regardless of whether 1 or 7 day treat)
31
Q

What are severe symptoms of complicated VVC?

A

extensive vulvar erythema, edema, excoriations, fissures

32
Q

What is the therapy for complicated VVC (severe symptoms)?

A
  • fluconazole 150 mg po q72h (3 days) for 2 or 3 doses
  • miconazole 7 day or clotrimazole 6 day pv regimens (and repeat once if needed)
  • (maybe) clotrimazole 500 mg pv x 2 doses (days 1 and 4)
  • longer duration of therapy
33
Q

What is recurrent VVC?

A

≥ 4 episodes in 12 months of symptomatic VVC

  • usually azole-susceptible C. albicans
  • reason for it unknown, but possibly due to localized vaginal allergic response, impaired Candida-specific cell-mediated immunity
34
Q

Do partners have to be treated for recurrent VVC?

A

if male partner is symptomatic, apply azole cream BID to penis x 7 days

35
Q

What is the therapy for recurrent VVC (complicated)?

A

10-14 days of induction therapy with vaginal agent or oral fluconazole, followed by fluconazole 150 mg po weekly for 6 months

induction:

  • fluconazole 150 mg po q72h x 3 doses (day 1, 4, 7) OR
  • azole pv for 12-14 days (6 or 7 day pv, repeated once)

THEN maintenance:

  • fluconazole 150 mg capsule po once weekly x 6 months (preferred)
  • clotrimazole 500 mg tablet pv once weekly x 6 months
  • clotrimazole 200 mg tablet pv twice weekly x 6 months
  • boric acid 600 mg capsule pv once weekly x 6 months
36
Q

What is the causative organism for VVC in patients with diabetes?

A
  • C. glabrata (60%)
  • C. albicans (40%)
37
Q

What is the causative organism for VVC in patients with abnormal immune function (other than diabetes)?

A
  • C. tropicalis
  • C. parapsilosis
  • C. krusei (1%)
38
Q

Describe the susceptibility of C. glabrata, C. tropicalis, and C. krusei to azoles.

A
  • C. glabrata responds poorly to azoles
  • C. tropicalis may not respond to azoles
  • C. krusei unresponsive to oral azoles, but responds well to vaginal azoles
39
Q

What is the treatment for complicated VVC caused by other organisms?

A
  • boric acid 600 mg pv QHS x 14 days (cures 70% C. glabrata infections)
  • nystatin vaginal cream 25 000 unit/g: 5g pv BID x 14 days (reasonable activity against C. glabrata)
40
Q

What is the drug of choice to treat pregnant patients with VVC (complicated)?

A

vaginal azole antifungals

  • recommend minimal systemic exposure, therefore little risk of harm to baby
  • increased efficacy with 7-day therapy over shorter durations
  • no greater benefit from longer durations (ie. > 14 days)
41
Q

What drug is used to treat pregnant patients with VVC (complicated)?

A

nystatin

  • considered safe in all trimesters
  • may be less effective than vaginal imidazoles
42
Q

What drug are NOT recommended to treat pregnant patients with VVC (complicated)?

A

oral fluconazole

  • safety concerns – MSK/conotruncal/cardiac malformations, oral clefts
  • single dose of oral fluconazole 150 mg is second-line option

boric acid

  • association with major malformations
  • > 2x increased risk of birth defects with use during first 4 months of pregnancy
43
Q

What is the therapy for complicated VVC in patients with abnormal immune function?

A

if C. albicans still suspected, suggest longer duration:

  • fluconazole 150 mg q72 h x 3 doses
  • 6 or 7 day vaginal azole regimens (may repeat)
44
Q

What drugs for VVC are compatible in lactation?

A
  • clotrimazole
  • nystatin
  • fluconazole
45
Q

What drugs for VVC are probably compatible in lactation?

A

miconazole

46
Q

What are the 2 monitoring points for VVC?

A

symptoms of VVC

  • endpoint: eradication of symptoms (itching, burning, dysuria, dyspareunia, lumpy white discharge)
  • action: if symptoms still present after 7 days, confirm correct use of product or consult physician

side effects of drug

  • endpoint: no increased irritation, common side effects of specific drug
  • action: D/C product if necessary, consider 3 or 7 day treatment if appropriate, refer to physician if severe irritation
47
Q

What is trichomoniasis?

A

anaerobic parasitic protozoan Trichomonas vaginalis

  • most common non-viral STI
  • lasts for months to years
48
Q

What is the treatment for trichomoniasis?

A
  • metronidazole 2 g po single dose, whether symptomatic or not
  • metronidazole 500 mg po BID x 7 days
49
Q

What is the treatment for trichomoniasis if persistent/recurrent infection?

A
  • metronidazole 500 mg po BID x 7 days
  • metronidazole 2 g po daily x 5 - 7 days
50
Q

What is the treatment for trichomoniasis if pregnant and symptomatic?

A
  • infection associated with pre-term delivery
  • metronidazole 500 mg po BID x 7 days
  • metronidazole 2 g po single dose
51
Q

What are the interactions in the treatment of trichomoniasis?

A
  • avoid alcohol – disulfiram-like reaction, vaginal treatment is not effective
  • stop breastfeeding during treatment with metronidazole and for 12-24 hours after last dose (pump and dump)
52
Q

What is bacterial vaginosis (BV)?

A

polymicrobial syndrome with replacement of normal Lactobacillus with high concentrations of anaerobic bacteria (Gardnerella vaginalis, and Mobiluncus, Mycoplasma, Prevotella, and Bacteroides species)

53
Q

What are the risk factors for BV?

A

multiple sex partners, copper IUD), prior pregnancy, smoking, vaginal douches or intravaginal products

54
Q

Is BV sexually transmitted?

A

maybe, but not considered STI

  • no treatment necessary for sexual partner
55
Q

Treatment of BV is reserved for patients with…

A

bothersome symptoms or special consideration (ie. pregnancy, IUD insertion, gynecologic surgery, etc.)

56
Q

What is the treatment for BV?

A
  • metronidazole 500 mg po bid x 7 days
  • metronidazole 0.75 % gel (5 g applicator of gel) pv daily x 5 days
  • clindamycin 2 % cream (5 g applicator of cream) pv daily x 7 days
57
Q

What are the alternative treatments for BV?

A
  • metronidazole 2g po single dose
  • clindamycin 300mg capsule po bid x 7 days
58
Q

What is the treatment for BV if pregnant?

A

oral metronidazole or clindamycin preferred

  • do NOT recommend vaginal therapy
59
Q

What is the treatment for BV if recurrent infection?

A
  • refer to physician to reconfirm diagnosis
  • metronidazole 500 mg po BID x 10-14 days
  • if not effective: metronidazole 0.75% gel (5 g app) pv daily x 10 days, then continue twice weekly for 3-6 months, also suggest regular condom use
60
Q

What is post-menopausal atrophic vaginitis (PMAV)?

A
  • tissue/organ becoming smaller, thinner, or weaker
  • low estrogen levels after menopause may result in: thinning of vaginal tissues, loss of vaginal elasticity, dryness, irritation, itching, burning, pain during intercourse
61
Q

What are the risk factors for PMAV?

A

hypoestrogenism, cigarette smoking, low androgen levels, non-vaginal childbirth

62
Q

What is the treatment for PMAV?

A
  • vaginal moisturizers and/or vaginal estrogen depending on severity
  • PMAV does not improve over time without treatment
  • like VVC, trichomoniasis, and BV, medical history alone is not adequate for making accurate diagnosis because symptoms overlap and more than one cause may be present – pelvic exam may also be needed